Cybin Inc (CYBN) Business News Jan. 05, 2026, 12:30 UTC HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq Full text
Register to leave comments News bot Jan. 5, 2026, 12:38 p.m. 📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical